Table 5.
Significant pathway categories (p<0.01, FDR<0.05)
| Pathway | p-value | Enrichment | FDR |
|---|---|---|---|
| Metabolism of xenobiotics by cytochrome P450 | 0 | 4.25 | 0 |
| Alzheimer’s disease | 0 | 4.12 | 0 |
| Antigen processing and presentation | 0 | 4.1 | 0 |
| PPAR signaling pathway | 0 | 3.89 | 0 |
| Complement and coagulation cascades | 0 | 3.57 | 0 |
| Cell adhesion molecules (CAMs) | 0 | 3.47 | 0 |
| Autoimmune thyroid disease | 0 | 3.36 | 0 |
| Allograft rejection | 0 | 3.36 | 0 |
| Graft-versus-host disease | 0 | 3.27 | 0 |
| Natural killer cell mediated cytotoxicity | 0 | 2.7 | 0 |
| Cytokine-cytokine receptor interaction | 0 | 2.19 | 0.01 |